Vaccination: Clinical Trials

4 trials for Vaccination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 11Completed 1

Follow Vaccination: new trials by email Literature Review of Vaccination trials Research Report on Vaccination

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial
Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP - Measles, Rubella
Phase 1 / Phase 2CompletedMicron Biomedical, Inc2812021-05-192023-03-29
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
Autologous Dendritic Cells (DC) vaccine, Temozolomide - Glioblastoma, Vaccination
Phase 2UnknownIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS282021-03-252025-07-22
A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Autologous DC vaccine, Interleukin-2 - Head Neck Tumors, Neuroendocrine Tumors
Phase 2RecruitingIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS512019-12-122024-09-19
Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC
boost radiotherapy (XRT), Autologous DC vaccine, High-Dose IL-2 - Carcinoma, Renal Cell, Vaccination
Phase 2WithdrawnIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2016-03-012018-11-13

Narrower conditions

Carcinoma, Renal Cell (1)  ·  Glioblastoma (1)  ·  Head and Neck Neoplasms (1)  ·  Measles (1)  ·  Neoplasm Metastasis (1)  ·  Neuroendocrine Tumors (1)  ·  Rubella (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Adenocarcinoma (1)  ·  Astrocytoma (1)  ·  Carcinoma (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glioma (1)  ·  Infections (1)  ·  Kidney Diseases (1)

Interventions

Interleukin-2 (2)  ·  Temozolomide (1)  ·  Vaccines (1)

Sponsors

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (3)  ·  Micron Biomedical, Inc (1)

Countries

Italy (3)  ·  The Gambia (1)

Top investigators

Laura Ridolfi, MD (2)  ·  Ed Clarke, MD (1)  ·  Laura Ridolfi, DR (1)

Results publications

PMID 36104719

NIH funding

2015 (1)